Cervical cancer (CC) is a major gynecological problem in develo** and underdeveloped
countries. Despite the significant advancement in early detection and treatment modalities …

Human papillomaviruses (HPVs) are small double‐stranded circular DNA viruses with 8 kb
genomes. So far, more than 150 HPVs have been identified, and 12 types of HPVs have …

BACKGROUND Cervical cancer is the second leading cause of cancer deaths among
women worldwide. The objective of this study was to describe the most common oncogenic …

High-risk human papilloma virus (HPV) infections cause cancers in different organ sites,
most commonly cervical and head and neck cancers. While carcinogenesis is initiated by …

Radiotherapy has a proven potential to eradicate cancer stem cells which is reflected by its
curative potential in many cancer types. Considerable progress has been made in …

The most important prognostic variables of cervical carcinoma are FIGO stage, lymph node
status and clinical-pathological features of primary tumor. Recently, there has been …

Cervical cancers/CCs are one of the commonest malignancies and the second leading
cause of cancer-related death in women. Resveratrol inhibits CC cell growth but its …

Cytokine research is currently at the forefront in cancer research. Deciphering the functions
of these multiple small molecules, discovered within the cell and in intercellular spaces, with …

The epidermal growth factor receptor (EGFR) is a type I transmembrane protein, which is a
member of the human epidermal growth factor receptor (HER) family of receptor tyrosine …

The high-risk (HR) human papillomaviruses (HPV) are causative agents of anogenital tract
dysplasia and cancers and a fraction of head and neck cancers. The HR HPV E6 …